"I Didn't Really Have a Choice": Qualitative Analysis of Racial-Ethnic Disparities in Diabetes Technology Use Among Young Adults with Type 1 Diabetes
- PMID: 33761284
- PMCID: PMC8501459
- DOI: 10.1089/dia.2021.0075
"I Didn't Really Have a Choice": Qualitative Analysis of Racial-Ethnic Disparities in Diabetes Technology Use Among Young Adults with Type 1 Diabetes
Abstract
Background: Racial-ethnic disparities in diabetes technology use are well documented in young adults (YA) with type 1 diabetes (T1D), but modifiable targets for intervention still need to be identified. Our objective was to explore YA perspectives on technology access and support in routine clinical care. Materials and Methods: Participants were YA with T1D of Hispanic or non-Hispanic Black race-ethnicity from pediatric and adult endocrinology clinics in the Bronx, NY. We conducted semistructured individual interviews to explore how health care and personal experiences affected technology use. Interviews were audio-recorded and transcribed for analysis. We used a modified inductive coding approach with two independent coders and iterative coding processes to improve data reliability and validity. Results: We interviewed 40 YA with T1D: mean age 22 years; 62% female; 72% Medicaid insured; 72% Hispanic; 28% non-Hispanic Black; and mean hemoglobin A1C 10.3%. Themes were categorized into potentially exacerbating and alleviating factors of racial-ethnic disparities in technology use. Exacerbating factors included perceptions that providers were gatekeepers of information and prescription access to technology, providers did not employ shared decision making for use, and YA biases against technology were left unaddressed. Alleviating factors included provider optimism and tailoring of technology benefits to YA needs, and adequate Medicaid insurance coverage. Conclusions: Our results reveal potential intervention targets at the provider level to increase technology uptake among underrepresented YA with T1D. Diabetes health care providers need to be aware of inadvertent withholding of information and prescription access to technology. Provider approaches that address YA technology concerns and promote shared decision making help to mitigate racial/ethnic disparities in technology use.
Keywords: Continuous glucose monitor; Health care disparities; Insulin pump technology; Type 1 diabetes; Young adults.
Conflict of interest statement
S.A. has done health care disparities advising for Medtronic.
Figures
Similar articles
-
Racial-Ethnic Disparities in Diabetes Technology use Among Young Adults with Type 1 Diabetes.Diabetes Technol Ther. 2021 Apr;23(4):306-313. doi: 10.1089/dia.2020.0338. Epub 2020 Dec 1. Diabetes Technol Ther. 2021. PMID: 33155826 Free PMC article.
-
Racial-Ethnic Inequity in Young Adults With Type 1 Diabetes.J Clin Endocrinol Metab. 2020 Aug 1;105(8):e2960-9. doi: 10.1210/clinem/dgaa236. J Clin Endocrinol Metab. 2020. PMID: 32382736 Free PMC article.
-
A Retrospective Cohort Study of Racial/Ethnic and Socioeconomic Disparities in Initiation and Meaningful Use of Continuous Glucose Monitoring Among Youth With Type 1 Diabetes.J Diabetes Sci Technol. 2024 Nov;18(6):1433-1444. doi: 10.1177/19322968231183985. Epub 2023 Jul 3. J Diabetes Sci Technol. 2024. PMID: 37394962 Free PMC article.
-
Building an Infrastructure to Address Racial Disparities in Treatment and Outcomes in Children with Type 1 Diabetes.Endocrinol Metab Clin North Am. 2025 Jun;54(2):217-224. doi: 10.1016/j.ecl.2025.03.004. Epub 2025 Apr 11. Endocrinol Metab Clin North Am. 2025. PMID: 40348563 Review.
-
Cardiovascular Impact of Race and Ethnicity in Patients With Diabetes and Obesity: JACC Focus Seminar 2/9.J Am Coll Cardiol. 2021 Dec 14;78(24):2471-2482. doi: 10.1016/j.jacc.2021.06.020. J Am Coll Cardiol. 2021. PMID: 34886969 Review.
Cited by
-
Closed-loop systems: recent advancements and lived experiences.Expert Rev Med Devices. 2024 Oct;21(10):927-941. doi: 10.1080/17434440.2024.2406901. Epub 2024 Oct 10. Expert Rev Med Devices. 2024. PMID: 39390689 Free PMC article. Review.
-
Continuous Glucose Monitor: Reclaiming Type 2 Diabetes Self-efficacy and Mitigating Disparities.J Endocr Soc. 2024 Jun 27;8(8):bvae125. doi: 10.1210/jendso/bvae125. eCollection 2024 Jul 1. J Endocr Soc. 2024. PMID: 38974988 Free PMC article.
-
Solutions to Address Inequity in Diabetes Technology Use in Type 1 Diabetes: Results from Multidisciplinary Stakeholder Co-creation Workshops.Diabetes Technol Ther. 2022 Jun;24(6):381-389. doi: 10.1089/dia.2021.0496. Diabetes Technol Ther. 2022. PMID: 35138944 Free PMC article.
-
Improving access to diabetes technologies in children and young people with type 1 diabetes: Healthcare professionals' perspectives and views.Diabet Med. 2025 Jul;42(7):e70058. doi: 10.1111/dme.70058. Epub 2025 Apr 25. Diabet Med. 2025. PMID: 40279481 Free PMC article.
-
Benchmarking Diabetes Technology Use Among 21 U.S. Pediatric Diabetes Centers.Clin Diabetes. 2024 Winter;42(1):27-33. doi: 10.2337/cd23-0052. Epub 2023 Nov 1. Clin Diabetes. 2024. PMID: 38230344 Free PMC article.
References
-
- Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, et al. . Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464–1476 - PubMed
-
- Beck RW, Riddlesworth T, Ruedy K, et al. : Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections the diamond randomized clinical trial. JAMA 2017;317:371–378 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical